MISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that it will be presenting at the Noble Financial Capital Markets’ seventh annual equity conference in South Florida. Russell Skibsted, the Company’s Chief Financial Officer, will be presenting a corporate update, including an overview of its recent contract with the Biomedical Advanced Research and Development Authority (BARDA), with options valued at $118 million.
